Hantavirus cases spark surge in pharma and biotech stocks — here’s why

AI Summary

Surging Hantavirus cases have led to a notable increase in pharmaceutical and biotech stock prices. Investors are reacting to the potential for heightened demand in healthcare solutions following the outbreak.